生物植入物市场 - 全球产业规模、份额、趋势、机会和预测，按产品类型、材料、最终用户、地区和竞争细分，2019-2029F

2023 年全球生物植入物市场估值为 1,253 亿美元，预计在预测期内将强劲增长，到 2029 年复合年增长率为 10.70%。或帮助骨骼癒合。植入物织物的主要作用是透过最大限度地减少骨-植入物界面的移动来为骨折提供稳定性并促进有机骨恢復。生物植入物中常用的金属是钛及其合金，以其卓越的耐腐蚀性、高能量和生物相容性而闻名，使其广泛用作外科植入物。生物植入物是用来替代、支撑或增强生物结构的假体。它们由各种生物合成材料（例如胶原蛋白）和组织工程产品（例如人造皮肤）组成。生物植入物分为三大类：生物植入物，包括生物人工器官、细胞治疗及组织工程；生物化植入物，包括体内细胞衬里、技术植入物和生物混合系统；以及生物功能化植入物，包括表面功能化植入物和药物洗脱支架。在耳鼻喉科领域，生物植入物取得了非常成功的手术效果，有效调节了患者的生理功能，使他们能够过着有成效的生活。

主要市场驱动因素

老年人口增加

对微创手术的偏好不断上升

扩大治疗用途范围

技术进步

主要市场挑战

植入手术成本高昂

生物材料对接受体的适应

主要市场趋势

生活方式压力导致慢性病增加

基因工程生物材料

细分市场洞察

产品类型洞察

材料洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球生物植入物市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 依产品类型（心血管植体、脊椎植入物、骨科植体、牙科植体、眼科植体和其他植体）
  • 依材料（生物材料金属合金、陶瓷、聚合物和其他材料）
  • 按最终使用者（医院诊所、门诊手术中心、其他）
  • 按地区
  • 按公司划分 (2023)
• 市场地图

第 6 章：北美生物植入物市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 依产品类型
  • 按材质
  • 按最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲生物植入物市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 依产品类型
  • 按材质
  • 按最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区生物植入物市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 依产品类型
  • 按材质
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲生物植入物市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 依产品类型
  • 按材质
  • 按最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲生物植入物市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 依产品类型
  • 按材质
  • 按最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球生物植入物市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• BIOTRONIK SE Co. KG
• Invibio Limited
• Wright MedicalGroup NV
• Edwards Lifesciences Corporation
• MiMeDX Group Inc.
• Stryker Corporation
• Endo International plc
• Smith Nephews plc
• Zimmer Biomet Holdings Inc
• Ethicon Inc.

第 16 章：策略建议

第 17 章：关于我们免责声明

Global Bio-Implants Market was valued at USD 125.30 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 10.70% through 2029. Bio-implants are biosynthetic materials utilized in medical applications for the purpose of bone repair, replacement, or aiding in bone healing. The primary role of implant fabric is to provide stability to bone fractures and facilitate organic bone recovery by minimizing movement at the bone-implant interface. The metals commonly used in bio-implants are titanium and its alloys, known for their exceptional corrosion resistance, high energy, and biocompatibility, making them widely used as surgical implants. Bio-implants are prostheses employed to replace, support, or enhance biological structures. They consist of various biosynthetic materials such as collagen and tissue-engineered products like artificial skin. Bio-implants are categorized into three major groups: biological implants encompassing bioartificial organs, cell therapy, and tissue engineering; biologized implants comprising in-vivo cell lining, technical implants, and biohybrid systems; and biofunctionalized implants including surface-functionalized implants and drug-eluting stents. In the field of ENT, bio-implants have yielded highly successful surgical outcomes, effectively regulated patients' physiological functions and enabling them to lead productive lives.

Key Market Drivers

Rising Geriatric Population

The population of elderly individuals, aged 80 and above, is on the rise due to improved living standards and advancements in the medical field. Older adults tend to avoid lengthy medical treatments, which is expected to drive the demand for bio-implants in this age group in the coming years. Surgeons often avoid major operations in older patients due to concerns about medical complications, which contributes to market growth. The most common ailments among geriatric individuals are related to eyesight and joint issues. Addressing these conditions can be achieved through the use of retinal bioimplants and knee or hip joint replacements. Current market trends suggest that the elderly population is set to increase, with more noticeable effects in nations with a high HDI such as Korea and the United States. Considering the frequent use of bio-implants in orthopedic treatments, this development holds significant implications for the market. Hip fractures rank among the most prevalent catastrophic injuries among the elderly, often necessitating immediate surgery and anesthesia. Consequently, patients spend several weeks in the hospital, resulting in the utilization of 1.5 million hospital bed days each year. As per NICE recommendations, surgical intervention should be conducted on the same day as hospital admission or the following day. This approach is informed by the understanding that being bedridden with a hip fracture is an unpleasant, distressing, and debilitating experience for patients, who are unable to mobilize until the procedure is completed. Thus, the expanding geriatric population is driving the growth of the Bio-implant Market.

Rising Preference toward Minimally Invasive Surgeries

A significant trend observed in the bioimplants market is the increasing demand for minimally invasive surgeries. The ability to create precise incisions for accessing surgical points is a significant advantage of these procedures. Minimally invasive surgeries enable endoscopic and laparoscopic bio-implanting procedures, resulting in reduced pain and faster postoperative recovery.

Minimally invasive surgeries offer significant benefits in terms of reducing post-surgical complications, promoting quick recovery, and shortening hospital stays. Procedures such as laser surgery, endoscopy, and laparoscopy involve small incisions, effectively minimizing pain and morbidity while enhancing postoperative recovery. The convenience of minimally invasive surgeries also drives the utilization of small bioimplants, smart tools, and devices. As a result, the preference for minimally invasive surgeries is poised to grow, making it a key trend in the bioimplants market in the coming years.

Increasing Range of Therapeutic Uses

Bio-implants have a wide range of therapeutic applications in various domains such as orthopedics, cardiology, dentistry, neurology, and more. They play a crucial role in enhancing both the duration and quality of human life. Moreover, bio-implants are utilized in the treatment of skin burns or wounds resulting from surgical procedures. Additionally, the increasing aging population, which is more susceptible to chronic conditions like cardiovascular disease, orthopedic disorders, endovascular diseases, and dental disorders, is one of the key drivers behind the growth of the Bio-Implants Market. Numerous chronic diseases, such as gout, congenital and neuropathic disorders, and cardiovascular diseases (CVD), have sedentary lifestyles as their primary contributing factor. Consequently, the global market for bio-implants has witnessed significant growth.

Technological advancement

Technological advancements in bio-implant manufacturing, such as 3D printing, laser technology, and nanotechnology, have significantly enhanced the biocompatibility of these products. A key contributing factor to these advancements is the increased allocation of healthcare funding by governments worldwide. Several governmental organizations are collaborating with healthcare research firms and medical equipment manufacturers to introduce novel and more efficacious devices to the market. Post-acute myocardial heart attack, the inclusion of extracellular vesicles from stem cells in bio implants has shown improved cardiac performance. The growing prevalence of cardiovascular diseases globally serves as the primary driver for the expansion of this market segment. Moreover, the increasing geriatric population worldwide presents a promising avenue for market growth throughout the forecast period. For instance, as per a 2021 essay published by the American Heart Association, approximately 40,000 children undergo congenital heart surgery annually in the United States.

Key Market Challenges

High Cost of Implanting Procedures

Implant procedures are significantly expensive due to the high costs associated with importing implant materials and the expertise required by skilled surgeons. For instance, dental implants for a single tooth typically fall within the higher price range. Similarly, the costs of treating chronic conditions with essential organ implants are exorbitant. These include retinal implants, cardiac stents, spinal implants, and cosmetic implants, all of which have the potential to restrict market growth.

Biomaterial Adaptation to Receptive Bodies

The efficacy of embedded implants in the human body is directly correlated with the body's adaptation to the material. The likelihood of immune reactions in the body plays a crucial role in assessing this efficacy. Infections resulting from implant materials have been reported due to bacterial adhesion to biomaterials used for implants, which impacts market growth. Allergic reactions of the body to foreign implanted materials cause discomfort to patients. Treatment in such cases often involves the removal of the implanted material and its replacement with other materials compatible with the body. Challenges arise at the implantation site due to material rejection by the human body, which manifests as inflammation and infections in and around the implant site.

Key Market Trends

Increasing Chronic Diseases due to Stressful Lifestyles

Chronic diseases affecting the heart, kidneys, and liver are on the rise due to stressful lifestyles and unhealthy habits. These conditions often require treatments such as organ and tissue transplantation, as well as the use of bio-implants. Additionally, degenerative bone and joint problems pose significant challenges. The increasing global geriatric population presents a substantial opportunity for the growth of the bio-implants market. Orthopedic biological implants are preferred for joint replacements and strengthening, addressing deformities caused by natural, accidental, or congenital factors. The utilization of implants, such as pacemakers and stents, for treating cardiovascular diseases is also increasing. This growth is driven by the need for effective control and treatment of heart ailments in the aging population worldwide.

Genetically Engineered Biomaterials

Naturally occurring biomaterials, such as proteins, undergo selective modifications for tissue engineering purposes. This primarily involves cell adhesion, protein fusions, and their applications in gene delivery, cell encapsulation, coating, and drug delivery. These advancements are poised to enhance the growth prospects of the market. Genetically engineered biomaterials involve sequencing processes based on genetics, structure, molecular weights, and fusion chemistries. A surge in the production of biomaterials using physical and chemical combinations in genetic engineering is anticipated. This focused production of biomaterials through intrinsic research contributes to the improvement in the effectiveness of implants. One significant opportunity driving the expansion of the cosmetic biomaterial market is research aimed at developing artificial skin using specialized biomaterials. Various forms of sponges that combine fibrillar collagen and gelatin are under evaluation. The evaluation encompasses in vitro cellular responses and in vivo tissue reactions, including experimentation in a whole organism, such as in vivo cell lining.

Segmental Insights

Product TypeInsights

Based on the product type, the market is categorized into different segments including cardiovascular implants, spinal implants, orthopaedic implants, dental implants, ophthalmic implants, and other implants. Among these, cardiovascular implants dominate the market due to the increasing prevalence of cardiovascular diseases. The geriatric population is also growing, creating further growth opportunities in this segment. Various factors such as smoking, sedentary lifestyle of the young population, and high blood pressure contribute to the development of cardiovascular diseases. Bioimplants are commonly used for treating such conditions, with surgery being the preferred method for most patients. As a result, the market is expected to experience significant expansion throughout the forecast period, as indicated by the analysis.

Material Insights

Based on the material, the biomaterial metal alloys category emerged as the dominant segment in the bio-implant market in 2023 and is projected to maintain its position throughout the forecast period. Key drivers for the category include notable advantages such as superior tensile strength and corrosion resistance compared to ceramics and other materials. Noteworthy applications of biomaterial metals include dental implants, joint replacement implants, and pacemaker cases. Conversely, ceramic implants are anticipated to experience rapid growth during the forecast period. Ceramics have garnered significant attention due to their ability to fulfil crucial mechanical functions for tissue repair. Furthermore, the potential of bio-ceramics to stimulate bone regeneration tissues is expected to drive their adoption in the coming years.

Regional Insights

North America has a dominant presence in the Bio-Implants Market. It is observed to hold a significant share and is projected to maintain this trend in the forecast period without any notable variations. The market growth is primarily driven by the growing incidence of chronic illnesses and the availability of advanced healthcare infrastructure. Europe is the second largest market for bio-implants, attributed to government funding and support, a rise in the prevalence of orthopedic illnesses, and increased RD efforts. For instance, many pacemaker manufacturers focus on developing MRI-conditional and leadless pacemakers. Moreover, the increasing prevalence of cardiovascular diseases (CVD) leads to a higher number of CVD procedures, contributing to market expansion. Asia Pacific is expected to witness the fastest growth throughout the forecast period, primarily due to the rising prevalence of spinal cord injuries. This can be attributed to a significant increase in the number of traffic accidents. According to a 2019 study by Tokyo's Keio University, more than 100,000 individuals in Japan suffer from paralysis caused by spinal cord injuries. However, the recent approval of iPS technology in the country is likely to offer potential for bio-implant market growth in the future, providing assistance to such patients. Therefore, these aforementioned factors are anticipated to propel market growth in the region during the forecast period.

Key Market Players

BIOTRONIK SE Co. KG

Invibio Limited

Wright Medical Group N.V.

Edwards Lifesciences Corporation

MiMeDX Group Inc.

Stryker Corporation

Endo International plc

Smith Nephew plc

Zimmer Biomet Holdings Inc

Ethicon Inc.

Report Scope:

In this report, the Global Bio-Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio-Implants Market,By Product Type:

• Cardiovascular Implants
• Spinal Implants
• Orthopedic Implants
• Dental Implants
• Ophthalmic Implants
• Other Implants

Bio-Implants Market,By Material:

• Biomaterial Metal Alloys
• Ceramics
• Polymers
• Other Materials

Bio-Implants Market,By End User:

• Hospitals Clinics
• Ambulatory Surgical Centres
• Others

Bio-Implants Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bio-Implants Market.

Available Customizations:

Global Bio-Implants marketreport with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validations
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Bio-Implants Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Product Type (Cardiovascular Implants, Spinal Implants, Orthopaedic Implants, Dental Implants, Ophthalmic Implants, and Other Implants)
  • 5.2.2.By Material (Biomaterial Metal Alloys, Ceramics, Polymers, and Other Materials)
  • 5.2.3.By End User (Hospitals Clinics, Ambulatory Surgical Centres, Others)
  • 5.2.4.By Region
  • 5.2.5.By Company (2023)
• 5.3.Market Map

6.North America Bio-Implants Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.ByProduct Type
  • 6.2.2.By Material
  • 6.2.3.By End User
  • 6.2.4.By Country
• 6.3.North America: Country Analysis
  • 6.3.1.United States Bio-Implants Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Product Type
      • 6.3.1.2.2.By Material
      • 6.3.1.2.3.By End User
  • 6.3.2.Canada Bio-Implants Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Product Type
      • 6.3.2.2.2.By Material
      • 6.3.2.2.3.By End User
  • 6.3.3.Mexico Bio-Implants Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Product Type
      • 6.3.3.2.2.By Material
      • 6.3.3.2.3.By End User

7.Europe Bio-Implants Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Product Type
  • 7.2.2.By Material
  • 7.2.3.By End User
  • 7.2.4.By Country
• 7.3.Europe: Country Analysis
  • 7.3.1.Germany Bio-Implants Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Product Type
      • 7.3.1.2.2.By Material
      • 7.3.1.2.3.By End User
  • 7.3.2.United Kingdom Bio-Implants Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Product Type
      • 7.3.2.2.2.By Material
      • 7.3.2.2.3.By End User
  • 7.3.3.Italy Bio-Implants Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecasty
      • 7.3.3.2.1.By Product Type
      • 7.3.3.2.2.By Material
      • 7.3.3.2.3.By End User
  • 7.3.4.France Bio-Implants Market Outlook
    • 7.3.4.1.Market Size Forecast
      • 7.3.4.1.1.By Value
    • 7.3.4.2.Market Share Forecast
      • 7.3.4.2.1.By Product Type
      • 7.3.4.2.2.By Material
      • 7.3.4.2.3.By End User
  • 7.3.5.Spain Bio-Implants Market Outlook
    • 7.3.5.1.Market Size Forecast
      • 7.3.5.1.1.By Value
    • 7.3.5.2.Market Share Forecast
      • 7.3.5.2.1.By Product Type
      • 7.3.5.2.2.By Material
      • 7.3.5.2.3.By End User

8.Asia-Pacific Bio-Implants Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Product Type
  • 8.2.2.By Material
  • 8.2.3.By End User
  • 8.2.4.By Country
• 8.3.Asia-Pacific: Country Analysis
  • 8.3.1.China Bio-Implants Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Product Type
      • 8.3.1.2.2.By Material
      • 8.3.1.2.3.By End User
  • 8.3.2.India Bio-Implants Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Product Type
      • 8.3.2.2.2.By Material
      • 8.3.2.2.3.By End User
  • 8.3.3.Japan Bio-Implants Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Product Type
      • 8.3.3.2.2.By Material
      • 8.3.3.2.3.By End User
  • 8.3.4.South Korea Bio-Implants Market Outlook
    • 8.3.4.1.Market Size Forecast
      • 8.3.4.1.1.By Value
    • 8.3.4.2.Market Share Forecast
      • 8.3.4.2.1.By Product Type
      • 8.3.4.2.2.By Material
      • 8.3.4.2.3.By End User
  • 8.3.5.Australia Bio-Implants Market Outlook
    • 8.3.5.1.Market Size Forecast
      • 8.3.5.1.1.By Value
    • 8.3.5.2.Market Share Forecast
      • 8.3.5.2.1.By Product Type
      • 8.3.5.2.2.By Material
      • 8.3.5.2.3.By End User

9.South America Bio-Implants Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Product Type
  • 9.2.2.By Material
  • 9.2.3.By End User
  • 9.2.4.By Country
• 9.3.South America: Country Analysis
  • 9.3.1.Brazil Bio-Implants Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Product Type
      • 9.3.1.2.2.By Material
      • 9.3.1.2.3.By End User
  • 9.3.2.Argentina Bio-Implants Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Product Type
      • 9.3.2.2.2.By Material
      • 9.3.2.2.3.By End User
  • 9.3.3.Colombia Bio-Implants Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Product Type
      • 9.3.3.2.2.By Material
      • 9.3.3.2.3.By End User

10.Middle East and Africa Bio-Implants Market Outlook

• 10.1.Market Size Forecast
  • 10.1.1.By Value
• 10.2.Market Share Forecast
  • 10.2.1.By Product Type
  • 10.2.2.By Material
  • 10.2.3.By End User
  • 10.2.4.By Country
• 10.3.MEA: Country Analysis
  • 10.3.1.South Africa Bio-Implants Market Outlook
    • 10.3.1.1.Market Size Forecast
      • 10.3.1.1.1.By Value
    • 10.3.1.2.Market Share Forecast
      • 10.3.1.2.1.By Product Type
      • 10.3.1.2.2.By Material
      • 10.3.1.2.3.By End User
  • 10.3.2.Saudi Arabia Bio-Implants Market Outlook
    • 10.3.2.1.Market Size Forecast
      • 10.3.2.1.1.By Value
    • 10.3.2.2.Market Share Forecast
      • 10.3.2.2.1.By Product Type
      • 10.3.2.2.2.By Material
      • 10.3.2.2.3.By End User
  • 10.3.3.UAE Bio-Implants Market Outlook
    • 10.3.3.1.Market Size Forecast
      • 10.3.3.1.1.By Value
    • 10.3.3.2.Market Share Forecast
      • 10.3.3.2.1.By Product Type
      • 10.3.3.2.2.By Material
      • 10.3.3.2.3.By End User

11.Market Dynamics

• 11.1.Drivers
• 11.2.Challenges

12.Market Trends Developments

• 12.1.Recent Development
• 12.2.Mergers Acquisitions
• 12.3.Product Launches

13.Global Bio-Implants Market: SWOT Analysis

14.Porter's Five Forces Analysis

• 14.1.Competition in the Industry
• 14.2.Potential of New Entrants
• 14.3.Power of Suppliers
• 14.4.Power of Customers
• 14.5.Threat of Substitute Products

15.Competitive Landscape

• 15.1.BIOTRONIK SE Co. KG
  • 15.1.1.Business Overview
  • 15.1.2.Company Snapshot
  • 15.1.3.Products Services
  • 15.1.4.Financials (As Reported)
  • 15.1.5.Recent Developments
  • 15.1.6.Key Personnel Details
  • 15.1.7.SWOT Analysis
• 15.2.Invibio Limited
• 15.3.Wright MedicalGroup N.V.
• 15.4.Edwards Lifesciences Corporation
• 15.5.MiMeDX Group Inc.
• 15.6.Stryker Corporation
• 15.7.Endo International plc
• 15.8.Smith Nephews plc
• 15.9.Zimmer Biomet Holdings Inc
• 15.10.Ethicon Inc.

16.Strategic Recommendations

17.About Us Disclaimer